Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.
primary studies published RCT
Details- 2005
- Cimmino M
Physiologic evidence for high-frequency chest wall oscillation and positive expiratory pressure breathing in hospitalized subjects with cystic fibrosis.
primary studies published RCT
Details- 2005
- Darbee JC
Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.
primary studies published RCT
Details- 2005
- Deterding R
Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.
primary studies published RCT
Details- 2005
- Dodd JD
Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!.
primary studies published RCT
Details- 2005
- Farrell PM
A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
primary studies published RCT
Details- 2005
- Fitzgerald DA
Short-term protein intake and stimulation of protein synthesis in stunted children with cystic fibrosis.
primary studies published RCT
Details- 2005
- Geukers VG
Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study.
primary studies published RCT
Details- 2005
- Grasemann H
Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients.
primary studies published RCT
Details- 2005
- Griese M
Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition.
primary studies published RCT
Details- 2005
- Hardin DS